̨ͼⱦ Launches New my̨ͼⱦ Native App to Expedite Study Start Up and Improve Patient Experience

Designed with customer and patient feedback to expand options for eCOA and other Decentralized Clinical Trial (DCT) activities

  • Powered by the new ̨ͼⱦ Designer build tool, the my̨ͼⱦ app is capable of significantly cutting study start-up times?
  • Full integration with ̨ͼⱦ platform including Rave EDC?
  • Patients can use their my̨ͼⱦ account interchangeably on the app, web-based portal, or bring your own or provisioned device, empowering patient choice and broadening access
  • The industrys only turn-key DCT solution is backed with ̨ͼⱦ䡯s trusted team of experts and exemplary data and privacy standards

?New York C December 6, 2022 C ̨ͼⱦ, a Dassault Systmes company, launched a new patient-centric native my̨ͼⱦ app, designed to provide trial participants with another option for a seamless platform experience and a single login for all their remote trial activities. The app will feature all of the my̨ͼⱦ patient-centric solutions, with an initial focus on eCOA (electronic clinical outcome assessments). The my̨ͼⱦ app is available on iOS and Android and can be used both on the patients own devices (BYOD) or via a provisioned device.

Our latest addition to my̨ͼⱦ brings an innovative app to patients designed in concert with our patient insights team, customer feedback, and the experiences derived from running the worlds biggest DCTs over the last twenty years, said Matt Noble, senior vice president, ̨ͼⱦ Patient Cloud. ̨ͼⱦ is leveraging its unique insights from sponsors, CROs, sites, and patients to make a meaningful difference in the clinical trial experience.

Unique to the industry, the my̨ͼⱦ app is unified with the ̨ͼⱦ Platform, including Rave EDC (electronic data capture), resulting in an entirely self-sustaining ecosystem where patient input, site based activities, and behind the scenes data management seamlessly operate together.?

The app is configured using ̨ͼⱦ Designer, a new platform configuration tool, bringing a patient-centered mobile-first workflow builder to the my̨ͼⱦ app. With Designer, sponsors and CRO partners can build a rich patient experience via intuitive drag and drop screen templates and visual workflow tools, which simultaneously in the background set up a clinical database without the need for any custom code. Designer drastically lowers study build times by employing ̨ͼⱦ and client libraries, including pre-built eCOA instruments, translations, and study configurations.

̨ͼⱦ is a wholly owned subsidiary of Dassault Systmes, which with its 3DEXPERIENCE platform is positioned to lead the digital transformation of life sciences in the age of personalized medicine with the first end-to-end scientific and business platform, from research to commercialization.

About ̨ͼⱦ
̨ͼⱦ is leading the digital transformation of life sciences, creating hope for millions of patients. ̨ͼⱦ helps generate the evidence and insights to help pharmaceutical, biotech, medical device and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 2,000+ customers and partners access the world's most trusted platform for clinical development, commercial, and real-world data. ̨ͼⱦ, a Dassault Systmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us

About Dassault Systmes

Dassault Systmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative 3D virtual environments to imagine sustainable innovations. By creating virtual twin experiences of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production to achieve a more sustainable world for patients, citizens, and consumers.? Dassault Systmes brings value to more than 300,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit

?3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA, and IFWE are commercial trademarks or registered trademarks of Dassault Systmes, a French socit europenne (Versailles Commercial Register # B 322 306 440), or its subsidiaries in the United States and/or other countries.


Tom Paolella
Senior Director, Corporate Communications & Affairs

Paul Oestreicher
External Communications Director